These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9642485)

  • 1. Treatment of angina pectoris with calcium antagonists: long-term follow-up.
    Behar S
    Cardiovasc Drugs Ther; 1998 Apr; 12 Suppl 1():119-24. PubMed ID: 9642485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic effects of calcium channel blockers on cardiac events, stroke and end-stage renal disease in patients with angina pectoris. Retrospective comparative study of benidipine, diltiazem and nifedipine.
    Arioka I; Dohi S; Dohi S; Sakai K
    Arzneimittelforschung; 2008; 58(9):435-40. PubMed ID: 18972872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group.
    Braun S; Boyko V; Behar S; Reicher-Reiss H; Laniado S; Kaplinsky E; Goldbourt U
    J Am Coll Cardiol; 1998 Mar; 31(4):804-8. PubMed ID: 9525550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-vitamin Treatment Modifies the Mortality Risk Associated with Calcium Channel Blockers in Patients with Suspected Stable Angina Pectoris: A Prospective Cohort Study.
    Dhar I; Svingen GF; Bjørnestad EØ; Ulvik A; Saeed S; Nygård OK
    Am J Clin Nutr; 2023 Jul; 118(1):77-84. PubMed ID: 37121550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonists.
    Yamagishi M; Ito K; Tsutsui H; Miyazaki S; Goto Y; Nagaya N; Sumiyoshi T; Fukami K; Haze K; Kitakaze M; Nonogi H; Tomoike H
    Circ J; 2003 Dec; 67(12):1029-35. PubMed ID: 14639019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis.
    Bangalore S; Parkar S; Messerli FH
    Am J Med; 2009 Apr; 122(4):356-65. PubMed ID: 19332231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of calcium-channel blockers for long-term clinical outcomes in patients with vasospastic angina.
    Kim SE; Jo SH; Han SH; Lee KY; Her SH; Lee MH; Seo WW; Cho SS; Baek SH
    Korean J Intern Med; 2021 Jan; 36(1):124-134. PubMed ID: 32088938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial.
    Poole-Wilson PA; Lubsen J; Kirwan BA; van Dalen FJ; Wagener G; Danchin N; Just H; Fox KA; Pocock SJ; Clayton TC; Motro M; Parker JD; Bourassa MG; Dart AM; Hildebrandt P; Hjalmarson A; Kragten JA; Molhoek GP; Otterstad JE; Seabra-Gomes R; Soler-Soler J; Weber S;
    Lancet; 2004 Sep 4-10; 364(9437):849-57. PubMed ID: 15351192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior calcium channel blockade and short-term survival following acute myocardial infarction.
    Parsons RW; Hung J; Hanemaaijer I; Jbroadhurst R; Jamrozik K; Hobbs MS
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):487-92. PubMed ID: 11916357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial.
    Lubsen J; Wagener G; Kirwan BA; de Brouwer S; Poole-Wilson PA;
    J Hypertens; 2005 Mar; 23(3):641-8. PubMed ID: 15716708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of calcium antagonists in the treatment of myocardial ischemia.
    Follath F
    Am Heart J; 1989 Nov; 118(5 Pt 2):1093-6; discussion 1096-7. PubMed ID: 2683702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
    Bulpitt CJ; Palmer AJ; Beevers DG; Coles EC; Ledingham JG; Petrie JC; Webster J
    J Hum Hypertens; 1997 Apr; 11(4):205-11. PubMed ID: 9185024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis.
    Jukema JW; van Boven AJ; Zwinderman AH; Van der Laarse A; Bruschke AV
    Cardiovasc Drugs Ther; 1998 Apr; 12 Suppl 1():111-8. PubMed ID: 9642484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS).
    Hjemdahl P; Eriksson SV; Held C; Forslund L; Näsman P; Rehnqvist N
    Heart; 2006 Feb; 92(2):177-82. PubMed ID: 15951393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choosing the most appropriate treatment for stable angina. Safety considerations.
    Asirvatham S; Sebastian C; Thadani U
    Drug Saf; 1998 Jul; 19(1):23-44. PubMed ID: 9673856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blockers and clinical outcomes in patients with continuous-flow left ventricular assist devices.
    Tie H; Li Z; Welp H; Guha A; Caraballo C; Deschka H; Shi R; Zheng X; Martens S; Sindermann J; Chen D; Wu Q; Martens S
    ESC Heart Fail; 2024 Feb; 11(1):271-281. PubMed ID: 37967837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
    Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
    Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.